Weighted Average Number of Shares Outstanding, Basic of Cocrystal Pharma, Inc. from 31 Mar 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cocrystal Pharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2013 to 30 Sep 2025.
  • Cocrystal Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 10,991,000, a 8% increase year-over-year.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 10,174,000, a 5.4% increase from 2023.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 9,651,000, a 19% increase from 2022.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8,143,000, a 11% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Cocrystal Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 10,991,000 +817,000 +8% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 10,174,000 0 0% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 10,174,000 0 0% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 10,174,000 +523,000 +5.4% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 10,174,000 +21,000 +0.21% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 10,174,000 +109,000 +1.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 10,174,000 +2,031,000 +25% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 9,651,000 +1,508,000 +19% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 10,153,000 +2,010,000 +25% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 10,065,000 +1,922,000 +24% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 8,143,000 0 0% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 8,143,000 +779,000 +11% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 8,143,000 0 0% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 8,143,000 -78,926,000 -91% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 8,143,000 -63,105,000 -89% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 7,364,000 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 8,143,000 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 87,069,000 +34,928,000 +67% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 71,248,000 +29,586,000 +71% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q2 2020 52,141,000 +20,520,000 +65% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 41,662,000 +11,325,000 +37% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q2 2019 31,621,000 +3,905,000 +14% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 30,337,000 +5,953,000 +24% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 28,009 -24,097,991 -100% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 29,923,000 -698,109,000 -96% 01 Jul 2018 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 27,716,000 +3,448,000 +14% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 24,384,000 +583,000 +2.4% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 24,126,000 +608,000 +2.6% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 728,032,000 +20,554,000 +2.9% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 24,268,000 -679,988,000 -97% 01 Apr 2017 30 Jun 2017 10-Q 09 Nov 2018 2018 Q3
Q1 2017 23,801,000 -672,348,000 -97% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 23,518,000 +2,507,000 +12% 01 Oct 2016 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q3 2016 707,478,000 +706,783,625 +101787% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 704,256,000 +703,563,796 +101641% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 696,149,000 +695,709,108 +158155% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 21,011,000 -305,768,000 -94% 01 Oct 2015 31 Dec 2015 10-K 21 Mar 2018 2017 FY
Q3 2015 694,375 +367,166 +112% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 692,204 +365,444 +112% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 439,892 +115,421 +36% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 326,779,000 +326,721,745 +570643% 01 Oct 2014 31 Dec 2014 10-K 31 Mar 2017 2016 FY
Q3 2014 327,209 +269,954 +471% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 326,760 +269,505 +471% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 324,471 +267,216 +467% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 57,255 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 57,255 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 57,255 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 57,255 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1

Cocrystal Pharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 10,174,000 +523,000 +5.4% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 9,651,000 +1,508,000 +19% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 8,143,000 +779,000 +11% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 7,364,000 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2019 31,859 +3,850 +14% 01 Jan 2019 31 Dec 2019 10-K 27 Mar 2020 2019 FY
2018 28,009 -24,097,991 -100% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 24,126,000 +608,000 +2.6% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 23,518,000 +2,507,000 +12% 01 Jan 2016 31 Dec 2016 10-K 21 Mar 2018 2017 FY
2015 21,011,000 -305,768,000 -94% 01 Jan 2015 31 Dec 2015 10-K 21 Mar 2018 2017 FY
2014 326,779,000 +326,721,745 +570643% 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2017 2016 FY
2013 57,255 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.